US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 13.490
  • -0.530-3.78%
Close May 7 16:00 ET
  • 13.630
  • +0.140+1.04%
Post 20:01 ET
1.32BMarket Cap168.63P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
297,063.33%89.15M
86.58M
2.07M
4,900.00%500K
0
-97.72%30K
0
0
-97.84%10K
-96.98%20K
Operating revenue
297,063.33%89.15M
--86.58M
--2.07M
4,900.00%500K
--0
-97.72%30K
--0
--0
-97.84%10K
-96.98%20K
Cost of revenue
977K
865K
112K
0
0
0
Gross profit
293,806.67%88.17M
85.72M
1.96M
30K
0
0
Operating expense
35.09%91.26M
276.68%38.52M
31.85%23.7M
-23.16%15.84M
-29.58%13.19M
83.40%67.55M
-33.78%10.23M
163.65%17.98M
202.78%20.61M
141.34%18.73M
Selling and administrative expenses
51.58%71.68M
420.26%35.49M
28.75%19.28M
-32.78%8.94M
-34.67%7.96M
156.20%47.28M
-36.44%6.82M
411.83%14.98M
441.29%13.31M
420.78%12.18M
Research and development costs
-3.38%19.58M
-11.08%3.03M
47.34%4.42M
-5.64%6.9M
-20.12%5.23M
10.29%20.27M
-27.73%3.4M
-22.89%3M
68.00%7.31M
20.82%6.55M
Operating profit
95.43%-3.08M
561.54%47.2M
-20.97%-21.75M
25.54%-15.34M
29.50%-13.19M
-90.11%-67.52M
33.78%-10.23M
-171.16%-17.98M
-224.76%-20.6M
-163.60%-18.71M
Net non-operating interest income expense
Other net income (expense)
-13.58%11.37M
-1.08%3.03M
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
1,477.34%13.16M
201.58%3.06M
6,521.28%3.11M
4,353.95%3.23M
2,584.77%3.75M
Other non- operating income (expenses)
-13.58%11.37M
-1.08%3.03M
-15.81%2.62M
-12.65%2.82M
-22.71%2.9M
1,250.62%13.16M
164.99%3.06M
6,521.28%3.11M
4,353.95%3.23M
2,584.77%3.75M
Income before tax
115.24%8.29M
800.64%50.22M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Income tax
288K
0
Net income
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Net income continuous Operations
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Minority interest income
Net income attributable to the parent company
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Basic earnings per share
114.04%0.08
828.57%0.51
-25.00%-0.2
27.78%-0.13
31.25%-0.11
34.48%-0.57
54.43%-0.07
-127.91%-0.16
-162.91%-0.18
-106.94%-0.16
Diluted earnings per share
114.04%0.08
828.57%0.51
-25.00%-0.2
27.78%-0.13
31.25%-0.11
34.48%-0.57
54.43%-0.07
-127.91%-0.16
-162.91%-0.18
-106.94%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 297,063.33%89.15M86.58M2.07M4,900.00%500K0-97.72%30K00-97.84%10K-96.98%20K
Operating revenue 297,063.33%89.15M--86.58M--2.07M4,900.00%500K--0-97.72%30K--0--0-97.84%10K-96.98%20K
Cost of revenue 977K865K112K000
Gross profit 293,806.67%88.17M85.72M1.96M30K00
Operating expense 35.09%91.26M276.68%38.52M31.85%23.7M-23.16%15.84M-29.58%13.19M83.40%67.55M-33.78%10.23M163.65%17.98M202.78%20.61M141.34%18.73M
Selling and administrative expenses 51.58%71.68M420.26%35.49M28.75%19.28M-32.78%8.94M-34.67%7.96M156.20%47.28M-36.44%6.82M411.83%14.98M441.29%13.31M420.78%12.18M
Research and development costs -3.38%19.58M-11.08%3.03M47.34%4.42M-5.64%6.9M-20.12%5.23M10.29%20.27M-27.73%3.4M-22.89%3M68.00%7.31M20.82%6.55M
Operating profit 95.43%-3.08M561.54%47.2M-20.97%-21.75M25.54%-15.34M29.50%-13.19M-90.11%-67.52M33.78%-10.23M-171.16%-17.98M-224.76%-20.6M-163.60%-18.71M
Net non-operating interest income expense
Other net income (expense) -13.58%11.37M-1.08%3.03M-15.81%2.62M-12.65%2.82M-22.71%2.9M1,477.34%13.16M201.58%3.06M6,521.28%3.11M4,353.95%3.23M2,584.77%3.75M
Other non- operating income (expenses) -13.58%11.37M-1.08%3.03M-15.81%2.62M-12.65%2.82M-22.71%2.9M1,250.62%13.16M164.99%3.06M6,521.28%3.11M4,353.95%3.23M2,584.77%3.75M
Income before tax 115.24%8.29M800.64%50.22M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Income tax 288K0
Net income 114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Net income continuous Operations 114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Minority interest income
Net income attributable to the parent company 114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Basic earnings per share 114.04%0.08828.57%0.51-25.00%-0.227.78%-0.1331.25%-0.1134.48%-0.5754.43%-0.07-127.91%-0.16-162.91%-0.18-106.94%-0.16
Diluted earnings per share 114.04%0.08828.57%0.51-25.00%-0.227.78%-0.1331.25%-0.1134.48%-0.5754.43%-0.07-127.91%-0.16-162.91%-0.18-106.94%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.99%
Sample Name
Sample Code
 +20.16%
Sample Name
Sample Code
 +20.08%
4
Qingdao Gaoce Technology
688556
+20.02%
5
Aerospace Nanhu Electronic Information Technology
688552
+20.02%
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 68.110
Sample Name
Sample Code
 188.710
Sample Name
Sample Code
 392.480
4
Salesforce
CRM
278.230
5
Meta Platforms
META
596.810
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 102.090
Sample Name
Sample Code
 144.300
Sample Name
Sample Code
 117.060
4
ASML Holding
ASML
700.390
5
Broadcom
AVGO
204.810
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1771
Sample Name
Sample Code
 11.350
Sample Name
Sample Code
 1.020
4
The9 Ltd
NCTY
10.610
5
Abits
ABTS
2.560
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -